A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal Injury
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine whether rabeprazole is superior to placebo in
preventing dyspepsia and gastroduodenal injury in subjects with osteoarthritis (OA) and/or
rheumatoid arthritis (RA) and/or bone pain.